KRAS pathway and mutations in cancer

Published on November 30, 2025   38 min

A selection of talks on Cancer

Please wait while the transcript is being prepared...
0:00
Hello. My name is Kayoko Tanaka. I'm a lecturer at the University of Leicester. I'd like to introduce the research topic of the KRAS Pathway and Mutations in Cancer.
0:15
My presentation consists of six parts as listed here. In the first three parts, I will summarize the structural and biochemical properties of KRAS and their relevance to oncogenic mutations. Next, I would like to introduce the importance of distinguishing between the effects of overexpression and endogenous expression of oncogenic KRAS mutants as these lead to different phenotypes. Following that, I will discuss the downstream pathways of KRAS. I will highlight the significance of the Raf-MEK-ERK signaling axis in KRAS oncogenic signaling. Finally, I would like to discuss the molecular insights into the KRAS-Rgl2-RalA/B signaling axis.
1:11
First, KRAS is an isoform of the Ras family of small GTPases.
1:19
Humans have three Ras genes, KRAS, HRAS, and NRAS. As the KRAS encodes two splice variants, KRAS4A and KRAS4B, there are four Ras isoforms as listed here. The diagram represents an NMR data-driven model of KRAS4B PDB entry 2MSD and is colored in the same way as the sequence alignment. These four isoforms are highly conserved at the N-terminal hub which consists of β1, α1, β2, β3, α2, and β4 and the linking unstructured parts P-loop, Switch I, Switch II. They further contribute to generating a guanine nucleotide binding pocket. Meanwhile, the C-terminal end is less conserved and hence is as termed the hypervariable region, which contains cysteine residues that receive lipid modifications that help the proteins to anchor at the plasma membrane. This is the same NMR data-driven model of KRAS4B that I just presented, but this time it includes the membrane nanodisc as the original modeled KRAS structure was analyzed. Mazhab-Jafari and his colleagues performed a paramagnetic relaxation enhancement analysis, type of NMR analysis, to examine the molecular orientation of KRAS in relation to the membrane nanodisc. The C-terminal hypervariable region is highlighted in purple and the guanine nucleotide is indicated in the model. Additionally, the modeled structure shows the position of the magnesium ion, which is essential for the proper folding of the KRAS protein. This study emphasizes the importance of considering the effects of the membrane when investigating KRAS function as the presence of the membrane can impose constraints on KRAS orientation and the accessibility of its interacting partners.

Quiz available with full talk access. Request Free Trial or Login.